The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 13, 2025

Filed:

Nov. 21, 2024
Applicant:

Transcend Therapeutics, Inc., New York, NY (US);

Inventors:

Bernard Cote, Notre-Dame-de-l'lle-Perrot, CA;

Jennifer Schmidt, Garden City, NY (US);

Martin Stogniew, Lakewood Ranch, FL (US);

Assignee:

TRANSCEND THERAPEUTICS, INC., New York, NY (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07F 9/655 (2006.01); A61K 9/00 (2006.01); A61K 31/665 (2006.01); C07D 317/48 (2006.01);
U.S. Cl.
CPC ...
C07F 9/65517 (2013.01); A61K 9/0019 (2013.01); A61K 9/0053 (2013.01); A61K 31/665 (2013.01); C07D 317/48 (2013.01);
Abstract

The subject matter disclosed generally relates to phenethylamines or cathinones covalently bound to a chemical moiety in a prodrug form. The presently described technology allows slow/sustained/controlled delivery of the parent phenethylamines or cathinones into the blood system in a manner that increase the duration of therapeutic efficacy, ease of application, patient compliance and/or a combination of these characteristics when administered, in particular, orally. Additionally, the described technology allows gradual release of the parent phenethylamines or cathinones over an extended period of time thereby eliminating spiking of drug levels which lessen cardiovascular stress, addiction/abuse potential and/or other common stimulant side effects associated with psychoactive compounds.


Find Patent Forward Citations

Loading…